Tag: Biotechnology

news-03122024-132148

Dr. Amoolya Singh Named Chief Technology Officer at DELFI Diagnostics

Dr. Amoolya Singh Appointed Chief Technology Officer at DELFI DiagnosticsIn a groundbreaking move that is set to redefine the landscape of cancer diagnostics, DELFI...
news-02122024-221249

Creating a Biorepository on the Moon: University of Minnesota Scientists Involved

Creating a Biorepository on the Moon: University of Minnesota Scientists InvolvedIn a groundbreaking initiative, scientists at the University of Minnesota are spearheading a project...
news-19062024-210956

Revolutionizing Drug Development: The Impact of Artificial Intelligence

In a state-of-the-art laboratory at Terray Therapeutics in Monrovia, California, a groundbreaking revolution in drug development is taking place. The lab is a hub...
theranos-founder-elizabeth-holmess-fraud-appeal-heard-in-court

Theranos founder Elizabeth Holmes’s fraud appeal heard in court

Theranos founder Elizabeth Holmes is appealing her conviction for defrauding investors in her blood-testing company. Her former partner and the startup's president, Ramesh "Sunny"...
chinas-nmpa-accepts-bla-for-zanidatamab-in-her2-biliary-tract-cancer

China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract Cancer

China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract CancerThe National Medical Products Administration (NMPA) in China has approved the biologics license application...
biopharmaceutical-market-to-reach-usd-18292-billion-by-2033-growing-at-154-cagr-dimension-market-research

Biopharmaceutical Market to Reach USD 1,829.2 Billion by 2033, Growing at 15.4% CAGR |...

Biopharmaceutical Market Poised to Surpass USD 1,829.2 Billion by 2033New York, June 10, 2024 (GLOBE NEWSWIRE) -- The Biopharmaceutical Market is on track to...
le-futur-post-covid-de-moderna-prend-forme-le-temps

Le futur post-covid de Moderna prend forme – Le Temps

Future of Moderna post-COVID taking shapeThe biotech company Moderna, like other players who benefited from the pandemic, is facing a sharp decline in COVID...
featured image 501

Cytosurge’s CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

Advancements in Cell Engineering TechnologyIn the realm of biotechnology, Cytosurge AG has made groundbreaking strides with its CellEDIT Workflow, which is based on its...

BREAKING NEWS

Top News